Characteristics of study participants at baseline
Did not develop HF (n=1346) | Developed HF (n=99) | P value | |
Age (years) | 78.1 (4.5) | 79.8 (4.9) | 0.0004 |
Smoking status | 0.42 | ||
Never smoked | 560 (38.6%) | 34 (34.3%) | |
Long-term ex-smoker | 720 (53.5%) | 55 (55.6%) | |
Recent ex-smoker | 62 (4.6%) | 4 (4.0%) | |
Current smoker | 43 (3.2%) | 6 (6.1%) | |
Prior myocardial infarction | 158 (11.7%) Missing=0 | 22 (22.2%) Missing=0 | 0.002 |
Prior stroke | 78 (5.8%) Missing=0 | 12 (12.1%) Missing=0 | 0.01 |
Diabetes mellitus | 214 (16.0%) Missing=5 | 15 (15.2%) Missing=0 | 0.83 |
Taking antihypertensive medication | 707 (52.5%) Missing=0 | 57 (57.6%) Missing=0 | 0.33 |
Physical measurements | |||
Body mass index (kg/m2) | 27.0 (3.8) Missing=11 | 27.7 (3.8) Missing=1 | 0.13 |
Systolic blood pressure (mm Hg) | 146 (18.8) Missing=1 | 144 (18.9) Missing=0 | 0.38 |
Diastolic blood pressure (mm Hg) | 76.6 (11.4) Missing=1 | 75.9 (11.4) Missing=0 | 0.61 |
Forced expiratory volume in 1 s (L) | 2.46 (0.56) Missing=35 | 2.24 (0.56) Missing=2 | 0.0002 |
Electrocardiographic measurements | |||
Left ventricular hypertrophy | 99 (7.4%) Missing=9 | 9 (8.1%) Missing=0 | 0.80 |
Atrial fibrillation | 93 (7.0%) Missing=9 | 16 (16.2%) Missing=0 | 0.0008 |
Q waves present | 75 (16.5%) Missing=9 | 24 (24.2%) Missing=0 | 0.047 |
Biomarkers | |||
Estimated glomerular filtration rate | 74.0 (17.5) Missing=62 | 71.7 (19.1) Missing=4 | 0.23 |
Interleukin-6 | 2.94 (1.76–4.34) Missing=77 | 3.37 (2.10–4.92) Missing=4 | 0.06 |
NT-pro-BNP | 121 (64.0–250) Missing=89 | 317 (133–746) Missing=6 | <0.0001 |
Frailty scores | |||
Fried phenotype | 0.047 | ||
Non-frail (0) | 400 (29.7%) | 18 (18.2%) | |
Prefrail (1) | 740 (55.0%) | 62 (62.6%) | |
Frail (2) | 206 (15.3%) | 19 (19.2%) | |
Gill-like score | 0.32 | ||
Mild or no frailty (0) | 1212 (90.0%) | 85 (85.9%) | |
Moderate frailty (1) | 97 (7.2%) | 9 (9.1%) | |
Severe frailty (2) | 37 (2.8%) | 5 (5.1%) | |
Novel frailty score | 0.013 | ||
0 | 967 (71.8%) | 57 (57.6%) | |
1 | 260 (19.3%) | 26 (26.3%) | |
2 | 76 (5.7%) | 9 (9.1%) | |
3 | 43 (3.2%) | 7 (7.1%) |
For normally distributed continuous variables, values are mean (SD) and p values for t tests; for NT-pro-BNP and interleukin-6, values are geometric mean (IQR) and p values for Kruskall-Wallis tests; for categorical variables values are N (% of total by column) and p values for χ2 tests.
HF, heart failure; NT-proBNP, N-terminal pro B-type natriuretic peptide.